When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DCPH - Blueprint's avapritinib pain is Deciphera's gain up 16%
Deciphera Pharmaceuticals Inc.
Deciphera Pharmaceuticals (NASDAQ:DCPH) is up 16% premarket on light volume on the heels on Blueprint Medicines' plunge after announcing unsuccessful results from late-stage study of avapritinib in gastrointestinal stromal tumor (GIST) patients.
More news on: Deciphera Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,